1-3 of 3
A. S. Ruppert
Close
Sort by
Journal Articles

Detection of Microdeletions and Amplifications in Primary Human Acute Myeloid Leukemia (AML) Genomes Using Ultradense Oligomer Tiling Path Arrays and Comparative Genomic Hybridization (CGH).

Matthew J. Walter, MD, R. R. Ries, BS, X. D. Li, W. J. Shannon, PhD, J. Payton, MD, PhD, C. D. Bloomfield, MD, K. Mrozek, MD, A. S. Ruppert, J. DiPersio, MD, PhD, D. Link, MD, M. Tomasson, MD, T. Graubert, MD, H. McLeod, PharmD, S. Devine, MD, M. Watson, MD, PhD, S. Heath, J. Baty, BA, K. Trinkaus, PhD, J. Armstrong, E. Mardis, PhD, R. Wilson, PhD, R. Selzer, PhD, T. Richmond, PhD, P. Eis, PhD, T. J. Ley, MD
Journal: Blood
Blood (2005) 106 (11): 2350.
https://doi.org/10.1182/blood.V106.11.2350.2350
Published: 2005
Journal Articles

Independent Validation of Prognostic Relevance of a Previously Reported Gene-Expression Signature in Acute Myeloid Leukemia (AML) with Normal Cytogenetics (NC): A Cancer and Leukemia Group B (CALGB) Study.

Guido Marcucci, M. D. Radmacher, A. S. Ruppert, K. Mrózek, J. E. Kolitz, S. P. Whitman, C. G. Edwards, J. W. Vardiman, M. A. Caligiuri, A. J. Carroll, R. A. Larson, C. D. Bloomfield
Journal: Blood
Blood (2005) 106 (11): 755.
https://doi.org/10.1182/blood.V106.11.755.755
Published: 2005
Journal Articles

t(8;21) Acute Myeloid Leukemia (AML) Differs from inv(16) AML in Pretreatment Characteristics, Outcome and Prognostic Factors Predicting Outcome: A Cancer and Leukemia Group B (CALGB) Study.

Guido Marcucci, K. Mrózek, A. S. Ruppert, K. Maharry, J. E. Kolitz, R. J. Mayer, M. J. Pettenati, B. L. Powell, C. G. Edwards, L. J. Sterling, J. W. Vardiman, C. A. Schiffer, A. J. Carroll, R. A. Larson, C. D. Bloomfield
Journal: Blood
Blood (2004) 104 (11): 2017.
https://doi.org/10.1182/blood.V104.11.2017.2017
Published: 2004